Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging tendency towards autoimmune process in major depressive patients: A novel insight from Th17 cells
Yili Chen, Tang Jiang, Peisong Chen, et al.
Psychiatry Research (2010) Vol. 188, Iss. 2, pp. 224-230
Closed Access | Times Cited: 178

Showing 1-25 of 178 citing articles:

The Bidirectional Relationship of Depression and Inflammation: Double Trouble
Eléonore Beurel, Marisa Toups, Charles B. Nemeroff
Neuron (2020) Vol. 107, Iss. 2, pp. 234-256
Open Access | Times Cited: 1387
New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors
Michaël Maes, Zdeněk Fišar, Miguel Medina, et al.
Inflammopharmacology (2012) Vol. 20, Iss. 3, pp. 127-150
Closed Access | Times Cited: 310
Neuroplastic changes in depression: A role for the immune system
Harris A. Eyre, Bernhard T. Baune
Psychoneuroendocrinology (2012) Vol. 37, Iss. 9, pp. 1397-1416
Closed Access | Times Cited: 292
Beyond a neurotransmitter: The role of serotonin in inflammation and immunity
Hera Wu, Travis Denna, Jordan Storkersen, et al.
Pharmacological Research (2018) Vol. 140, pp. 100-114
Closed Access | Times Cited: 266
TNFα disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice
Yuyan Cheng, Sachi Desse, Ana Martı́nez, et al.
Brain Behavior and Immunity (2018) Vol. 69, pp. 556-567
Open Access | Times Cited: 218
Immune targets for therapeutic development in depression: towards precision medicine
Wayne C. Drevets, Gayle Wittenberg, Edward T. Bullmore, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 3, pp. 224-244
Open Access | Times Cited: 200
Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut–brain pathways
Marta Martín-Subero, George Anderson, Buranee Kanchanatawan, et al.
CNS Spectrums (2015) Vol. 21, Iss. 2, pp. 184-198
Open Access | Times Cited: 193
Tryptophan Metabolism in Depression: A Narrative Review with a Focus on Serotonin and Kynurenine Pathways
Ana Salomé Correia, Nuno Vale
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8493-8493
Open Access | Times Cited: 173
The Brain–Skin Axis in Psoriasis—Psychological, Psychiatric, Hormonal, and Dermatological Aspects
Luiza Marek‐Józefowicz, Rafał Czajkowski, Alina Borkowska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 669-669
Open Access | Times Cited: 79
Inflammation in the pathogenesis of depression: a disorder of neuroimmune origin
Myles Corrigan, Aoife M. O’Rourke, Barry Moran, et al.
Neuronal Signaling (2023) Vol. 7, Iss. 2
Open Access | Times Cited: 47
High-cholesterol diet promotes depression- and anxiety-like behaviors in mice by impact gut microbe and neuroinflammation
Lili Zou, Yaling Tian, Yuanfei Wang, et al.
Journal of Affective Disorders (2023) Vol. 327, pp. 425-438
Closed Access | Times Cited: 45
Inflammatory mediators in major depression and bipolar disorder
Sara Poletti, Mario Gennaro Mazza, Francesco Benedetti
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 27
Th17 cells in depression
Eléonore Beurel, Jeffrey A. Lowell
Brain Behavior and Immunity (2017) Vol. 69, pp. 28-34
Open Access | Times Cited: 156
Targeting IL-1 in depression
Michaël Maes, Cai Song, Raz Yirmiya
Expert Opinion on Therapeutic Targets (2012) Vol. 16, Iss. 11, pp. 1097-1112
Closed Access | Times Cited: 152
Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects
Adrian L. Lopresti, Sean Hood, Peter D. Drummond
Journal of Psychopharmacology (2012) Vol. 26, Iss. 12, pp. 1512-1524
Open Access | Times Cited: 142
Oxidative/Nitrosative Stress and Immuno-inflammatory Pathways in Depression: Treatment Implications
George Anderson, Michaël Maes
Current Pharmaceutical Design (2014) Vol. 20, Iss. 23, pp. 3812-3847
Closed Access | Times Cited: 139
IL-17A causes depression-like symptoms via NFκB and p38MAPK signaling pathways in mice: Implications for psoriasis associated depression
Ahmed Nadeem, Sheikh F. Ahmad, Naif O. Al‐Harbi, et al.
Cytokine (2017) Vol. 97, pp. 14-24
Closed Access | Times Cited: 130
Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation
Andrew H. Miller, Ebrahim Haroon, Jennifer C. Felger
Neuropsychopharmacology (2016) Vol. 42, Iss. 1, pp. 334-359
Open Access | Times Cited: 127
Reduced regulatory T cells are associated with higher levels of Th1/TH17 cytokines and activated MAPK in type 1 bipolar disorder
Carine Hartmann do Prado, Lucas B. Rizzo, Andréa Wieck, et al.
Psychoneuroendocrinology (2012) Vol. 38, Iss. 5, pp. 667-676
Closed Access | Times Cited: 122
Th17 Pathway-Mediated Immunopathogenesis of Schizophrenia: Mechanisms and Implications
Monojit Debnath, Michael Berk
Schizophrenia Bulletin (2014) Vol. 40, Iss. 6, pp. 1412-1421
Open Access | Times Cited: 114
Potential roles of zinc in the pathophysiology and treatment of major depressive disorder
Walter Swardfager, Nathan Herrmann, Roger S. McIntyre, et al.
Neuroscience & Biobehavioral Reviews (2013) Vol. 37, Iss. 5, pp. 911-929
Closed Access | Times Cited: 104
Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy
Laura Grosse, Lívia A. Carvalho, Tom K. Birkenhäger, et al.
Psychopharmacology (2015) Vol. 233, Iss. 9, pp. 1679-1688
Closed Access | Times Cited: 103
Microbiota, Immunoregulatory Old Friends and Psychiatric Disorders
G.A.W. Rook, Charles L. Raison, Christopher A. Lowry
Advances in experimental medicine and biology (2014), pp. 319-356
Closed Access | Times Cited: 99
T helper 17 cell/regulatory T-cell imbalance in hidradenitis suppurativa/acne inversa: the link to hair follicle dissection, obesity, smoking and autoimmune comorbidities
Bodo C. Melnik, Swen Malte John, W. Chen, et al.
British Journal of Dermatology (2018)
Closed Access | Times Cited: 95
Involvement of Innate and Adaptive Immune Systems Alterations in the Pathophysiology and Treatment of Depression
Eva M. Medina‐Rodríguez, Jeffrey A. Lowell, Ryan J. Worthen, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 89
Page 1 - Next Page

Scroll to top